|
(Summaries
on http://www.ncbi.nlm.nih.gov)
| 1. |
Keim
V, Rohr G, Stockert HG, Haberich FJ. An additional secretory
protein in the rat pancreas. Digestion. 1984;29:242-9.
|
| 2. |
Orelle
B, Keim V, Masciotra L, Dagorn JC, Iovanna JL.Human
pancreatitis-associated protein. Messenger RNA cloning
and expression in pancreatic diseases. J Clin Invest.
1992;90,2284-91.
|
| 3. |
Iovanna
JL, Keim V, Michel R, Dagorn JC. Pancreatic gene expression
is altered during acute experimental pancreatitis in
the rat. Am J Physiol. 1991;261:G485-9.
|
| 4. |
Iovanna
J, Keim V, Nordback I, Montalto G, Camarena J, Letoublon
C, Levy P, Berthézène P, Dagorn JC. Serum levels of
Pancreatitis Associated Protein as indicators of the
course of acute pancreatitis. Multicentric Study Group
on Acute Pancreatitis. Gastroenterology 1994 ;106, 728-734
|
| 5. |
Piper
SN, Kumle B, Maleck WH, Suttner SW, Fent MT, Boldt J.
Effects of postoperative sedation with propofol and
midazolam on pancreatic function assessed by pancreatitis-associated
protein. Anaesthesia. 2001;56:836-40.
|
| 6. |
Piper
SN, Suttner SW, Maleck WH, Kumle B, Haisch G, Boldt
J. Effects of sodium nitroprusside-induced controlled
hypotension on pancreatic function assessed by pancreatitis-associated
protein in patients undergoing radical prostatectomy.
Eur J Anaesthesiol. 2002;19:609-13
|
| 7. |
Nordback
I, Jaakkola M, Iovanna JL, Dagorn JC. Increased serum
pancreatitis associated protein (PAP) concentration
after longterm alcohol consumption: further evidence
for regular subclinical pancreatic damage after heavy
drinking ? Gut. 1995;36:117-20
|
| 8. |
Van
der Pijl JW, Boonstra JG, Barthellemy S, Smets YF, Hermans
J, Bruijn JA, de Fijter JW, Daha MR, Dagorn JC. Pancreatitis-associated
protein: a putative marker for pancreas graft rejection.
Transplantation. 1997;63:995-1003.
|
| 9. |
Iovanna
JL, Ferec C, Sarles J, Dagorn JC. The pancreatitis-associated
protein (PAP). A new candidate for neonatal screening
of cystic fibrosis.C R Acad Sci III. 1994;317:561-4.
|
| 10. |
Sarles
J, Barthellemy S, Ferec C, Iovanna J, Roussey M, Farriaux
JP, Toutain A, Berthelot J, Maurin N, Codet JP, Berthezene
P, Dagorn JC. Blood concentrations of pancreatitis associated
protein in neonates: relevance to neonatal screening
for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed.
1999 ; 80:F118-22.
|
| 11. |
Barthellemy
S, Maurin N, Roussey M, Ferec C, Murolo S, Berthezene
P, Iovanna JL, Dagorn JC, Sarles J. Evaluation of 47,213
infants in neonatal screening for cystic fibrosis, using
pancreatitis-associated protein and immunoreactive trypsinogen
assays Arch Pediatr. 2001;8:275-81.
|
| 12. |
Sarles
J, Berthezene P, Le Louarn C, Somma C, Perini JM, Catheline
M, Mirallie S, Luzet K, Roussey M, Farriaux JP, Berthelot
J, Dagorn JC. Combining immunoreactive trypsinogen and
pancreatitis-associated protein assays, a method of newborn
screening for cystic fibrosis that avoids DNA analysis.
J Pediatr. 2005;147:302-5. |
| 13. |
Carroccio
A, Iovanna JL, Iacono G, Li Pani M, Montalto G, Cavataio
F, Marasa L, Barthellemy-Bialas S, Dagorn JC. Pancreatitis-associated
protein in patients with celiac disease: serum levels
and immunocytochemical localization in small intestine.
Digestion. 1997;58:98-103. |
| 14. |
Desjeux
A, Barthet M, Barthellemy S, Dagorn JC, Hastier P, Heresbach
D, Bernard JP, Grimaud JC. Serum measurements of pancreatitis
associated protein in active Crohn's disease with ileal
location. Gastroenterol Clin Biol. 2002;26:23-8. |
| 15. |
Gironella
M, Iovanna JL, Sans M, Gil F, Penalva M, Closa D, Miquel
R, Pique JM, Panes J. Anti-inflammatory effects of pancreatitis
associated protein in inflammatory bowel disease. Gut.
2005;54:1244-53. |
| 16. |
Duplan
L, Michel B, Boucraut J, Barthellemy S, Desplat-Jego S,
Marin V, Gambarelli D, Bernard D, Berthezene P, Alescio-Lautier
B, Verdier JM. Lithostathine and Pancreatitis-associated
protein are involved in the very early stages of Alzheimer's
disease. Neurobiol Aging, 2001 ;22 :79-88. |
| 17. |
Montalto
G, Iovanna JL, Soresi M, Dusetti N, Carroccio A, Barthellemy-Bialas
S, Cartabellotta A, Dagorn JC. Clinical evaluation of
pancreatitis-associated protein as a serum marker of hepatocellular
carcinoma: comparison with alpha-fetoprotein. Oncology.
1998;55:421-5. |
| 18. |
Rosty
C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot
F, Chan DW, Canto M, Lillemoe KD, Cameron JL, Yeo CJ,
Hruban RH, Goggins M. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated
protein I as a biomarker for pancreatic ductal adenocarcinoma
by protein biochip technology. Cancer Res. 2002;62:1868-75 |
| 19. |
Cerwenka
H, Aigner R, Bacher H, Werkgartner G, el-Shabrawi A, Quehenberger
F, Mischinger HJ. Pancreatitis-associated protein (PAP)
in patients with pancreatic cancer. Anticancer Res. 2001;21:1471-4 |
| 20. |
Motoo
Y, Satomura Y, Mouri I, Mouri H, Ohtsubo K, Sakai J, Fujii
T, Taga H, Yamaguchi Y, Watanabe H, Okai T, Sawabu N.
Serum levels of pancreatitis-associated protein in digestive
diseases with special reference to gastrointestinal cancers.
Dig Dis Sci. 1999 ;44:1142-7 |
| 21. |
Motoo
Y, Watanabe H, Yamaguchi Y, Xie MJ, Mouri H, Ohtsubo K,
Okai T, Wakabayashi T, Sawabu N. Pancreatitis-associated
protein levels in pancreatic juice from patients with
pancreatic diseases. Pancreatology. 2001;1:43-7 |
 |
.